Cancer Profiling Market Share, Size, Growth, Drivers & Opportunities

Global Cancer Profiling Market Research Report: Forecast (2024-2030)

Cancer Profiling Market Share - By Type of Cancer (Breast Cancer, Colorectal Cancer, Gynecological Cancer, Leukemia, Prostate Cancer, Lung Cancer, Others), By Technology (Next-Generation Sequencing, P... ... ration Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays Analysis, Others), By Biomarker Type (Genomic Biomarkers, Proteomics Biomarkers, Others), By Cell Type (Germline, Somatic) and others Read more

Healthcare
Dec 2023
Pages 202
Report Format: PDF, Excel, PPT

Market Definition

Cancer profiling involves the study of cancerous genes, proteins, and other biomarkers of patients suffering from several oncological disorders including breast cancer and prostate cancer among others. Cancer profiling services include the usage of advanced technologies for sequencing biomarkers like next-generation sequencing, microarrays, etc. Also, some of the major applications of these services are gene expression analysis, mutation detection, personalized medicine, clinical diagnostics, etc.

Market Insights & Analysis: Global Cancer Profiling Market (2024-30):

The Global Cancer Profiling Market size is estimated to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30. The major factors responsible for the market growth include; the rising prevalence of cancer, increasing research on cancer therapies, and the launch of improved technologies for tumor profiling among others. There has been an increase in the number of cancer cases globally, especially across the US, India, etc., as stated by various healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, the Global Cancer Observatory, etc.

Consequently, as cancer cases have been increasing considerably, the need to manage them has also enhanced. Hence, countries, especially the US, India, etc., were taking measures to control cancer cases, which has been leading to increased awareness among patients. This has led to an increased need for tumor profiling testing services across the globe to cater to the demand for early-stage detection and diagnosis services.

Report Coverage	Details
Study Period	Historical Data: 2019-22
	Base Year: 2023
	Forecast Period: 2024-30
CAGR (2024-2030)	11.5%
Regions Covered	North America: US, Canada, Mexico
	Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
	Asia-Pacific: China, India, Japan, South Korea, Australia, Singapore, Rest of Asia-Pacific
	South America: Brazil, Rest of South America
	Middle East & Africa: GCC, South Africa, Rest of MEA
Key Companies Profiled	NeoGenomics Laboratories, Eurofins Genomics GmbH, F. Hoffmann-La Roche Ltd (Foundation Medicine) , OncoDNA SA, 10x Genomics, Inc., Caris Life Sciences., Geneseeq Technology Inc., Genetron , Holdings Limited, Laboratory Corporation of America Holdings (LabCorp), Dante Labs Inc., Celemics, Inc., Strand Life Sciences, Myriad Genetics, Inc., QIAGEN GmbH, Tempus Labs, Others
Unit Denominations	USD Million/Billion

Also, it has been observed that global cancer research and healthcare organizations predict that cancer cases are projected to amplify in the coming years, which would further generate the demand for cancer profiling services. The prediction has been based on increasing carcinogenic pollutants in the atmospheres responsible for causing cancer, along with the rising prevalence of genetic mutations, which would lead to cancer. For instance,

As per World Cancer Research Fund International, the new cancer cases are expected to grow to nearly 29 million by 2040, especially across countries with a low Human Development Index (HDI), i.e., countries with low life expectancy, low standard of living and financial wealth, etc.

Additionally, there has been a surging geriatric population globally, which is further projected to grow due to the growing life expectancy, and increasing adoption of healthy lifestyles among them. The increasing geriatric population would further contribute to the rise in the prevalence of cancer disease patients, because, the geriatric population is more susceptible to cancer owing to age-related genetic changes and a weakened immune system. For instance,

According to the United Nations Department of Economic and Social Affairs, as of 2019, over 0.7 billion individuals were aged 65 or above, and the statistics are anticipated to reach about 1 billion by 2030.

Thus, the incessant surge in the old-age population would further create a need for cancer diagnosis techniques including genetic panels and profiling in the upcoming years.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Sequencing Revolution, 2000-2022
1. Genome Sequencing
2. Protein Sequencing
Global Cancer Profiling Market Clinical Trial Analysis, 2019-2023
Global Cancer Profiling Market Trends & Insights
Global Cancer Profiling Market Dynamics
1. Drivers
2. Challenges
Global Cancer Profiling Market Hotspot & Opportunities
Global Cancer Profiling Market Policies & Regulations
Global Cancer Profiling Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Cancer
    1. Breast Cancer - Market Size & Forecast 2019-2030, USD Million
    2. Colorectal Cancer - Market Size & Forecast 2019-2030, USD Million
    3. Gynecological Cancer - Market Size & Forecast 2019-2030, USD Million
    4. ‎Leukemia - Market Size & Forecast 2019-2030, USD Million
    5. Prostate Cancer - Market Size & Forecast 2019-2030, USD Million
    6. Lung Cancer - Market Size & Forecast 2019-2030, USD Million
    7. Others (Pancreatic Cancer, Skin Cancer, etc.) - Market Size & Forecast 2019-2030, USD Million
  2. By Technology
    1. Next-Generation Sequencing - Market Size & Forecast 2019-2030, USD Million
    2. Polymerase Chain Reaction - Market Size & Forecast 2019-2030, USD Million
    3. Mass Spectrometry - Market Size & Forecast 2019-2030, USD Million
    4. In-Situ Hybridization - Market Size & Forecast 2019-2030, USD Million
    5. Microarrays Analysis - Market Size & Forecast 2019-2030, USD Million
    6. Others (Single-Cell Sequencing, etc.) - Market Size & Forecast 2019-2030, USD Million
  3. By Biomarker Type
    1. Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million
    2. Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million
    3. Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million
  4. By Cell Type
    1. Germline - Market Size & Forecast 2019-2030, USD Million
    2. Somatic - Market Size & Forecast 2019-2030, USD Million
  5. By Application
    1. Oncology Research - Market Size & Forecast 2019-2030, USD Million
    2. Precision Medicine - Market Size & Forecast 2019-2030, USD Million
    3. Clinical Diagnostics - Market Size & Forecast 2019-2030, USD Million
    4. Others (Prognosis, Monitoring and Recurrence Detection, etc.) - Market Size & Forecast 2019-2030, USD Million
  6. By End-User
    1. Hospitals and Clinics - Market Size & Forecast 2019-2030, USD Million
    2. Research Institutions and Laboratories - Market Size & Forecast 2019-2030, USD Million
    3. Diagnostic Service Providers - Market Size & Forecast 2019-2030, USD Million
    4. Pharmaceutical and Biotechnology Companies - Market Size & Forecast 2019-2030, USD Million
  7. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia Pacific
  8. By Company
    1. Competition Characteristics
    2. Market Share & Analysis
North America Cancer Profiling Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
  2. By Technology - Market Size & Forecast 2019-2030, USD Million
  3. By Biomarker Type - Market Size & Forecast 2019-2030, USD Million
  4. By Cell Type - Market Size & Forecast 2019-2030, USD Million
  5. By Application - Market Size & Forecast 2019-2030, USD Million
  6. By End-User - Market Size & Forecast 2019-2030, USD Million
  7. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
4. Canada Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
5. Mexico Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
South America Cancer Profiling Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
  2. By Technology - Market Size & Forecast 2019-2030, USD Million
  3. By Biomarker Type - Market Size & Forecast 2019-2030, USD Million
  4. By Cell Type - Market Size & Forecast 2019-2030, USD Million
  5. By Application - Market Size & Forecast 2019-2030, USD Million
  6. By End-User - Market Size & Forecast 2019-2030, USD Million
  7. By Country
    1. Brazil
    2. Rest of South America
3. Brazil Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
Europe Cancer Profiling Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
  2. By Technology - Market Size & Forecast 2019-2030, USD Million
  3. By Biomarker Type - Market Size & Forecast 2019-2030, USD Million
  4. By Cell Type - Market Size & Forecast 2019-2030, USD Million
  5. By Application - Market Size & Forecast 2019-2030, USD Million
  6. By End-User - Market Size & Forecast 2019-2030, USD Million
  7. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
3. The UK Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
4. Germany Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
5. France Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
6. Italy Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
7. Spain Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
Middle East & Africa Cancer Profiling Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
  2. By Technology - Market Size & Forecast 2019-2030, USD Million
  3. By Biomarker Type - Market Size & Forecast 2019-2030, USD Million
  4. By Cell Type - Market Size & Forecast 2019-2030, USD Million
  5. By Application - Market Size & Forecast 2019-2030, USD Million
  6. By End-User - Market Size & Forecast 2019-2030, USD Million
  7. By Country
    1. GCC
    2. South Africa
    3. Rest of Middle East & Africa
3. GCC Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
4. South Africa Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
Asia Pacific Cancer Profiling Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
  2. By Technology - Market Size & Forecast 2019-2030, USD Million
  3. By Biomarker Type - Market Size & Forecast 2019-2030, USD Million
  4. By Cell Type - Market Size & Forecast 2019-2030, USD Million
  5. By Application - Market Size & Forecast 2019-2030, USD Million
  6. By End-User - Market Size & Forecast 2019-2030, USD Million
  7. By Country
    1. China
    2. India
    3. Japan
    4. Australia
    5. South Korea
    6. Singapore
    7. Rest of Asia-Pacific
3. China Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
4. India Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
5. Japan Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
6. Australia Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
7. South Korea Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
8. Singapore Cancer Profiling Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type of Cancer - Market Size & Forecast 2019-2030, USD Million
    2. By Technology - Market Size & Forecast 2019-2030, USD Million
    3. By End-User - Market Size & Forecast 2019-2030, USD Million
Global Cancer Profiling Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Company Profiles
  1. NeoGenomics Laboratories
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Eurofins Genomics GmbH
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. F. Hoffmann-La Roche Ltd (Foundation Medicine)
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. OncoDNA SA
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. 10x Genomics, Inc.
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Caris Life Sciences.
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Geneseeq Technology Inc.
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Genetron Holdings Limited
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Laboratory Corporation of America Holdings (LabCorp)
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Dante Labs Inc.
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Celemics, Inc.
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Strand Life Sciences
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Myriad Genetics, Inc.
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. QIAGEN GmbH
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. Tempus Labs
    1. Business Description
    2. Technology Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  16. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying